|
|
|
|
|
Quarterly Performance
|
Qtr Ended |
Revenues |
Net Income |
EPS |
| 03 / 2003
|
47476 |
-12475 |
|
| 06 / 2003
|
27513 |
-60818 |
|
| 09 / 2003
|
47260 |
-14964 |
|
| 12 / 2003
|
49504 |
38435 |
|
| 03 / 2004
|
55125 |
-24247 |
|
| 06 / 2004
|
52177 |
-27106 |
|
| 09 / 2004
|
51733 |
-39721 |
|
| 12 / 2004
|
63297 |
-15092 |
|
|
|
|
|
Major Stock Holders
(Prior To
Offering) |
Name |
|
Alkermes, Inc. |
NA |
NA |
NA |
NA |
NA |
NA |
|
Bay City Capital LLC |
NA |
NA |
NA |
NA |
NA |
NA |
|
Joseph J. Krivulka |
NA |
NA |
NA |
NA |
NA |
NA |
|
Michael B. Solomon |
NA |
NA |
NA |
NA |
NA |
NA |
|
PharmBay Investors, L.L.C. |
NA |
NA |
NA |
NA |
NA |
NA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 2002
|
177355 |
297519 |
-120164 |
0.00 |
-120719 |
0.00 |
| 2003
|
171754 |
274678 |
-102924 |
305 |
-49821 |
0.00 |
| 2004
|
222332 |
325524 |
-103192 |
-267 |
-106167 |
0.00 |
| 2005
|
40649 |
84781 |
-44132 |
8 |
-47905 |
0.00 |
|
|
|
Balance Sheet Data
|
Year |
Cash |
Acct Recv. |
Inventory |
Total Cur Assets |
Total Cur Liability |
PPE |
Total Assets |
LT Debt |
SH Equity |
|
2003 |
94712 |
2015 |
9971 |
135085 |
105122 |
0.00 |
259623 |
0.00 |
-482328 |
|
2004 |
58348 |
18141 |
23334 |
118910 |
96354 |
0.00 |
239902 |
93371 |
-651194 |
|
2005 |
29912 |
14650 |
24677 |
82427 |
100275 |
0.00 |
196881 |
93575 |
-742499 |
|
|
|
| Cash
Flow Summary
|
Year |
Net Cash-Ops |
Net Cash-Inv |
Net Cash-Fin |
Net Change |
|
2002 |
-102127 |
-2149 |
70386 |
-33890 |
|
2003 |
-30409 |
-107545 |
200447 |
62493 |
|
2004 |
-117913 |
-20324 |
101873 |
-36364 |
|
2005 |
-24537 |
-1638 |
-2261 |
-28436 |
|
|
| |
|
| |